Compare Stocks: TEM, LH, DGX, and GH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$244.34 +1.3%	$219.35	$171.18 ▼ $245.68	$26.97B	0.56	864,489 shs	1.26 million shs
GH Guardant Health	$170.69 +1.7%	$153.91	$53.40 ▼ $176.58	$22.91B	1.6	2.28 million shs	1.91 million shs
LH Labcorp	$336.03 +1.0%	$292.52	$244.52 ▼ $338.19	$27.28B	0.87	697,313 shs	792,662 shs
TEM Tempus AI	$72.69 +9.1%	$52.93	$40.77 ▼ $104.32	$13.12B	3.58	6.89 million shs	15.90 million shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	0.00%	+4.20%	+7.40%	+25.15%	+32.63%
GH Guardant Health	0.00%	+8.57%	+13.64%	+43.50%	+191.78%
LH Labcorp	0.00%	+5.66%	+15.68%	+29.06%	+20.89%
TEM Tempus AI	0.00%	+39.52%	+57.99%	+57.41%	-0.81%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$244.34 +1.3%	$219.35	$171.18 ▼ $245.68	$26.97B	0.56	864,489 shs	1.26 million shs
GH Guardant Health	$170.69 +1.7%	$153.91	$53.40 ▼ $176.58	$22.91B	1.6	2.28 million shs	1.91 million shs
LH Labcorp	$336.03 +1.0%	$292.52	$244.52 ▼ $338.19	$27.28B	0.87	697,313 shs	792,662 shs
TEM Tempus AI	$72.69 +9.1%	$52.93	$40.77 ▼ $104.32	$13.12B	3.58	6.89 million shs	15.90 million shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	0.00%	+4.20%	+7.40%	+25.15%	+32.63%
GH Guardant Health	0.00%	+8.57%	+13.64%	+43.50%	+191.78%
LH Labcorp	0.00%	+5.66%	+15.68%	+29.06%	+20.89%
TEM Tempus AI	0.00%	+39.52%	+57.99%	+57.41%	-0.81%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DGX Quest Diagnostics	2.54	Moderate Buy	$235.31	-3.70% Downside
GH Guardant Health	2.96	Moderate Buy	$183.78	7.67% Upside
LH Labcorp	2.75	Moderate Buy	$330.00	-1.79% Downside
TEM Tempus AI	2.41	Hold	$65.69	-9.63% Downside

Current Analyst Ratings Breakdown

Latest TEM, LH, DGX, and GH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/20/2026	TEM Tempus AI	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$70.00 ➝ $80.00
8/12/2026	DGX Quest Diagnostics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Buy (B+) ➝ Buy (A-)
8/12/2026	TEM Tempus AI	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/10/2026	LH Labcorp	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$355.00
8/4/2026	GH Guardant Health	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$170.00 ➝ $195.00
8/4/2026	TEM Tempus AI	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$58.00 ➝ $56.00
8/4/2026	GH Guardant Health	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$135.00 ➝ $193.00
8/4/2026	GH Guardant Health	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$175.00 ➝ $185.00
8/4/2026	LH Labcorp	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$300.00 ➝ $309.00
8/3/2026	LH Labcorp	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$330.00 ➝ $360.00
8/3/2026	TEM Tempus AI	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$80.00 ➝ $70.00

(Data available from 8/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DGX Quest Diagnostics	$11.04B	2.44	$15.17 per share	16.11	$64.78 per share	3.77
GH Guardant Health	$982.02M	23.33	N/A	N/A	($0.79) per share	-216.06
LH Labcorp	$13.95B	1.95	$24.80 per share	13.55	$103.98 per share	3.23
TEM Tempus AI	$1.27B	10.31	N/A	N/A	$2.76 per share	26.34

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DGX Quest Diagnostics	$992M	$9.42	25.94	20.41	2.25	9.18%	16.01%	7.27%	10/20/2026 (Estimated)
GH Guardant Health	-$416.28M	-$3.49	N/A	N/A	N/A	-38.33%	N/A	-25.40%	10/28/2026 (Estimated)
LH Labcorp	$876.50M	$12.09	27.79	17.09	1.95	6.99%	16.74%	7.81%	10/27/2026 (Estimated)
TEM Tempus AI	-$245.03M	-$1.44	N/A	N/A	N/A	-17.77%	-50.28%	-10.33%	11/3/2026 (Estimated)

Latest TEM, LH, DGX, and GH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2026	Q2 2026	GH Guardant Health	-$0.7618	-$0.42	+$0.3418	-$0.90	$314.23 million	$334.98 million
7/30/2026	Q2 2026	LH Labcorp	$4.78	$4.99	+$0.21	$3.64	$3.71 billion	$3.73 billion
7/30/2026	Q2 2026	TEM Tempus AI	-$0.1428	-$0.04	+$0.1028	$0.03	$379.69 million	$382.49 million
7/23/2026	Q2 2026	DGX Quest Diagnostics	$2.82	$3.12	+$0.30	$2.84	$2.97 billion	$3.04 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DGX Quest Diagnostics	$3.44	1.41%	+7.34%	36.52%	14 Years
GH Guardant Health	N/A	N/A	N/A	N/A	N/A
LH Labcorp	$2.88	0.86%	N/A	23.82%	N/A
TEM Tempus AI	N/A	N/A	N/A	N/A	N/A

Latest TEM, LH, DGX, and GH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/12/2026	DGX Quest Diagnostics	quarterly	$0.86	1.45%	10/6/2026	10/6/2026	10/21/2026
7/9/2026	LH Labcorp	quarterly	$0.72	1.04%	8/28/2026	8/28/2026	9/11/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DGX Quest Diagnostics	0.72	1.59	1.46
GH Guardant Health	N/A	4.03	3.71
LH Labcorp	0.69	1.80	1.53
TEM Tempus AI	3.06	3.30	3.16

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DGX Quest Diagnostics	88.06%
GH Guardant Health	92.60%
LH Labcorp	95.94%
TEM Tempus AI	24.22%

Insider Ownership

Company	Insider Ownership
DGX Quest Diagnostics	0.88%
GH Guardant Health	5.60%
LH Labcorp	0.84%
TEM Tempus AI	24.26%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DGX Quest Diagnostics	57,000	110.37 million	109.40 million	Optionable
GH Guardant Health	2,506	134.20 million	126.68 million	Not Optionable
LH Labcorp	71,000	81.10 million	80.42 million	Optionable
TEM Tempus AI	3,800	180.43 million	136.66 million	N/A

TEM, LH, DGX, and GH Headlines

Recent News About These Companies

Artificial Intelligence Stocks To Watch Today - August 23rd

August 23 at 12:00 PM | marketbeat.com

Tempus AI's Breakneck Rally Faces Its First Test: Can Fundamentals Keep Pace?

August 23 at 8:46 AM | ad-hoc-news.deA

Why Tempus AI Skyrocketed This Week

August 23 at 7:15 AM | fool.com

Promising Artificial Intelligence Stocks To Keep An Eye On - August 20th

August 23 at 3:02 AM | americanbankingnews.com

Tempus AI, Inc. (NASDAQ:TEM) Given Average Recommendation of "Hold" by Analysts

August 23 at 2:29 AM | americanbankingnews.com

Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Recommendation of "Hold" by Brokerages

August 23 at 2:28 AM | marketbeat.com

Tempus AI (NASDAQ:TEM) Trading 8.3% Higher Following Analyst Upgrade

August 23 at 1:41 AM | americanbankingnews.com

Artificial Intelligence Stocks To Follow Now - August 22nd

August 22 at 12:00 PM | marketbeat.com

Tempus AI: Winning With Precision Medicine

August 22 at 11:00 AM | seekingalpha.com

Has Tempus AI (TEM) Run Too Far Ahead Of Its Valuation Narrative?

August 22 at 9:05 AM | uk.finance.yahoo.com

What to Know About the CFO of Tempus AI's Latest Insider Transaction Filing

August 22 at 9:00 AM | fool.com

Tempus AI's Accounting Chief Just Reported an Insider Transaction. Here's What Long-Term Investors Should Know

August 22 at 9:00 AM | fool.com

Is Tempus AI Stock a Buy After Its 75% Rally? Here's What to Know as the Firm's Legal Chief Files a Trade

August 22 at 9:00 AM | fool.com

A Tempus AI Director Sold Stock Four Days Before a 24% Rally. Here's What to Know

August 22 at 8:19 AM | fool.com

Tempus AI's CEO Sold $6.6 Million in Stock the Day Before a Huge Rally. Here's What to Know

August 22 at 8:00 AM | fool.com

Tempus AI's Diagnostics Chief Filed Stock Sales Spanning a Volatile Week. Here's What Happened

August 22 at 7:40 AM | fool.com

Tempus AI's Data Chief Just Filed a Form 4. His Segment Grew 28% Last Quarter.

August 22 at 7:34 AM | fool.com

Tempus AI (NASDAQ:TEM) Stock Price Expected to Rise, BTIG Research Analyst Says

August 22 at 2:26 AM | americanbankingnews.com

Tempus AI (NASDAQ:TEM) Sees Large Volume Increase on Analyst Upgrade

August 22 at 1:40 AM | americanbankingnews.com

Tempus AI (NASDAQ:TEM) Trading 8.3% Higher on Analyst Upgrade

August 21 at 1:39 PM | marketbeat.com

Tempus AI Stock Climbs Friday: What's Driving the Move?

August 21 at 10:47 AM | benzinga.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TEM, LH, DGX, and GH Company Descriptions

Quest Diagnostics NYSE:DGX

$244.34 +3.04 (+1.26%)

As of 08/21/2026 03:58 PM Eastern

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Guardant Health NASDAQ:GH

$170.69 +2.81 (+1.67%)

As of 08/21/2026 04:00 PM Eastern

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Labcorp NYSE:LH

$336.03 +3.22 (+0.97%)

As of 08/21/2026 03:58 PM Eastern

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Tempus AI NASDAQ:TEM

$72.69 +6.04 (+9.06%)

As of 08/21/2026 04:00 PM Eastern

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TEM, LH, DGX, and GH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TEM, LH, DGX, and GH Earnings

Compare Dividends

Latest TEM, LH, DGX, and GH Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TEM, LH, DGX, and GH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

TEM, LH, DGX, and GH Company Descriptions

Quest Diagnostics NYSE:DGX

Guardant Health NASDAQ:GH

Labcorp NYSE:LH

Tempus AI NASDAQ:TEM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools